Evercore ISI Lowers Agilon Health (NYSE:AGL) Price Target to $3.00

Agilon Health (NYSE:AGL - Free Report) had its price target cut by Evercore ISI from $5.00 to $3.00 in a research note released on Wednesday,Benzinga reports. They currently have an in-line rating on the stock.

Several other research firms have also issued reports on AGL. Robert W. Baird lowered their price target on shares of Agilon Health from $6.00 to $5.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 15th. JMP Securities reissued a "market perform" rating on shares of Agilon Health in a report on Monday, April 28th. Citigroup upgraded Agilon Health from a "neutral" rating to a "buy" rating and increased their target price for the stock from $3.25 to $5.00 in a research report on Friday, April 25th. Barclays boosted their price objective on Agilon Health from $2.00 to $3.00 and gave the company an "underweight" rating in a research note on Thursday, May 8th. Finally, Wells Fargo & Company dropped their price objective on Agilon Health from $6.00 to $5.00 and set an "overweight" rating on the stock in a report on Tuesday, May 13th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Agilon Health presently has an average rating of "Hold" and an average price target of $4.71.

Agilon Health Trading Down 3.8%

Shares of NYSE:AGL traded down $0.09 during midday trading on Wednesday, reaching $2.30. The company had a trading volume of 2,311,572 shares, compared to its average volume of 4,788,288. The company's 50 day moving average price is $2.55 and its 200 day moving average price is $3.23. The stock has a market cap of $952.09 million, a P/E ratio of -3.90 and a beta of 0.16. Agilon Health has a 52-week low of $1.50 and a 52-week high of $7.73.

Agilon Health (NYSE:AGL - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.04. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.50 billion. Agilon Health had a negative net margin of 4.04% and a negative return on equity of 45.47%. The firm's quarterly revenue was down 4.5% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.02) EPS. Research analysts forecast that Agilon Health will post -0.59 EPS for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

Several hedge funds have recently bought and sold shares of the stock. Capital International Investors lifted its holdings in shares of Agilon Health by 72.0% during the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after acquiring an additional 9,346,295 shares during the last quarter. Millennium Management LLC grew its position in Agilon Health by 187.8% in the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after acquiring an additional 4,706,357 shares in the last quarter. Nuveen LLC purchased a new position in Agilon Health in the first quarter worth $17,242,000. Algert Global LLC grew its position in Agilon Health by 1,042.7% in the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock worth $4,007,000 after acquiring an additional 1,924,157 shares in the last quarter. Finally, CenterBook Partners LP purchased a new position in Agilon Health in the first quarter worth $8,315,000.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.